Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome

John P Fezza Center for Sight, Sarasota, FL, USA Purpose: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes.Methods: This was an institutional review board-approved, single-site, open-label, prospective study to assess...

Full description

Bibliographic Details
Main Author: Fezza JP
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/cross-linked-hyaluronic-acid-gel-occlusive-device-for-the-treatment-of-peer-reviewed-article-OPTH

Similar Items